<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35736349</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2076-3271</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>Medical sciences (Basel, Switzerland)</Title><ISOAbbreviation>Med Sci (Basel)</ISOAbbreviation></Journal><ArticleTitle>Connecting the Dots in Emerging Mast Cell Research: Do Factors Affecting Mast Cell Activation Provide a Missing Link between Adverse COVID-19 Outcomes and the Social Determinants of Health?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">29</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medsci10020029</ELocationID><Abstract><AbstractText>Evidence continues to emerge that the social determinants of health play a role in adverse outcomes related to COVID-19, including increased morbidity and mortality, increased risk of long COVID, and vaccine adverse effects. Therefore, a more nuanced understanding of the biochemical and cellular pathways of illnesses commonly associated with adverse social determinants of health is urgently needed. We contend that a commitment to understanding adverse outcomes in historically marginalized communities will increase community-level confidence in public health measures. Here, we synthesize emerging literature on mast cell disease, and the role of mast cells in chronic illness, alongside emerging research on mechanisms of COVID illness and vaccines. We propose that a focus on aberrant and/or hyperactive mast cell behavior associated with chronic underlying health conditions can elucidate adverse COVID-related outcomes and contribute to the pandemic recovery. Standards of care for mast cell activation syndrome (MCAS), as well as clinical reviews, experimental research, and case reports, suggest that effective and cost-efficient remedies are available, including antihistamines, vitamin C, and quercetin, among others. Primary care physicians, specialists, and public health workers should consider new and emerging evidence from the biomedical literature in tackling COVID-19. Specialists and researchers note that MCAS is likely grossly under-diagnosed; therefore, public health agencies and policy makers should urgently attend to community-based experiences of adverse COVID outcomes. It is essential that we extract and examine experiential evidence of marginalized communities from the broader political-ideological discourse.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>da Silveira Gorman</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Health Policy and Management, York University, 4700 Keele St., Toronto, ON M3J 1P3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syed</LastName><ForeName>Iffath Unissa</ForeName><Initials>IU</Initials><Identifier Source="ORCID">0000-0001-9568-3243</Identifier><AffiliationInfo><Affiliation>Health Policy and Administration, The Pennsylvania State University, 47 Shenango Ave, Sharon, PA 16146, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Med Sci (Basel)</MedlineTA><NlmUniqueID>101629322</NlmUniqueID><ISSNLinking>2076-3271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008407" MajorTopicYN="N">Mast Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064890" MajorTopicYN="N">Social Determinants of Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MCAS</Keyword><Keyword MajorTopicYN="N">adverse vaccine effects</Keyword><Keyword MajorTopicYN="N">autoimmune disease</Keyword><Keyword MajorTopicYN="N">chronic illness</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">environmental illness</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mast cells</Keyword><Keyword MajorTopicYN="N">neurological inflammation</Keyword><Keyword MajorTopicYN="N">social determinants of health</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>9</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35736349</ArticleId><ArticleId IdType="pmc">PMC9228930</ArticleId><ArticleId IdType="doi">10.3390/medsci10020029</ArticleId><ArticleId IdType="pii">medsci10020029</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kazama I. Stabilizing mast cells by commonly used drugs: A novel therapeutic target to relieve post-COVID syndrome? Drug Discov. Ther. 2020;14:259&#x2013;261. doi: 10.5582/ddt.2020.03095.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2020.03095</ArticleId><ArticleId IdType="pubmed">33116043</ArticleId></ArticleIdList></Reference><Reference><Citation>Noris M., Benigni A., Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020;98:314&#x2013;322. doi: 10.1016/j.kint.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7246017</ArticleId><ArticleId IdType="pubmed">32461141</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchand L., Pecquet M., Luyton C. Type 1 diabetes onset triggered by COVID-19. Geol. Rundsch. 2020;57:1265&#x2013;1266. doi: 10.1007/s00592-020-01570-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-020-01570-0</ArticleId><ArticleId IdType="pmc">PMC7353822</ArticleId><ArticleId IdType="pubmed">32653960</ArticleId></ArticleIdList></Reference><Reference><Citation>Omotosho Y.B., Ying G.W., Stolar M., Mallari A.J.P. COVID-19-Induced Diabetic Ketoacidosis in an Adult with Latent Autoimmune Diabetes. Cureus. 2021;13:e12690. doi: 10.7759/cureus.12690.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12690</ArticleId><ArticleId IdType="pmc">PMC7881111</ArticleId><ArticleId IdType="pubmed">33604221</ArticleId></ArticleIdList></Reference><Reference><Citation>Clouston S.A.P., Natale G., Link B.G. Socioeconomic inequalities in the spread of coronavirus-19 in the United States: A examination of the emergence of social inequalities. Soc. Sci. Med. 2021;268:113554. doi: 10.1016/j.socscimed.2020.113554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113554</ArticleId><ArticleId IdType="pmc">PMC7703549</ArticleId><ArticleId IdType="pubmed">33308911</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu J.Y. Health inequality experienced by the socially disadvantaged populations during the outbreak of COVID-19 in Hong Kong: An interaction with social inequality. Health Soc. Care Community. 2021;29:1522&#x2013;1529. doi: 10.1111/hsc.13214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.13214</ArticleId><ArticleId IdType="pubmed">33125773</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparyan A.Y., Misra D.P., Yessirkepov M., Zimba O. Perspectives of Immune Therapy in Coronavirus Disease 2019. J. Korean Med. Sci. 2020;35:e176. doi: 10.3346/jkms.2020.35.e176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e176</ArticleId><ArticleId IdType="pmc">PMC7211516</ArticleId><ArticleId IdType="pubmed">32383371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Selvakumar G.P., Ahmed M.E., Raikwar S.P., Thangavel R., Khan A., Zaheer S.A., Iyer S.S., Burton C., James D., et al. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation. Neuroscientist. 2020;26:402&#x2013;414. doi: 10.1177/1073858420941476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420941476</ArticleId><ArticleId IdType="pubmed">32684080</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill-Briggs F., Adler N.E., Berkowitz S.A., Chin M.H., Gary-Webb T.L., Navas-Acien A., Thornton P.L., Haire-Joshu D. Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care. 2020;44:258&#x2013;279. doi: 10.2337/dci20-0053.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci20-0053</ArticleId><ArticleId IdType="pmc">PMC7783927</ArticleId><ArticleId IdType="pubmed">33139407</ArticleId></ArticleIdList></Reference><Reference><Citation>Medvedyuk S., Ali A., Raphael D. Ideology, obesity and the social determinants of health: A critical analysis of the obesity and health relationship. Crit. Public Health. 2018;28:573&#x2013;585. doi: 10.1080/09581596.2017.1356910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09581596.2017.1356910</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams E.M., Szefler S.J. COVID-19 and the impact of social determinants of health. Lancet Respir. Med. 2020;8:659&#x2013;661. doi: 10.1016/S2213-2600(20)30234-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30234-4</ArticleId><ArticleId IdType="pmc">PMC7234789</ArticleId><ArticleId IdType="pubmed">32437646</ArticleId></ArticleIdList></Reference><Reference><Citation>Raphael D., Bryant T., Mikkonen J., Alexander R. Social Determinants of Health: The Canadian Facts. Faculty of Health Sciences, Ontario Tech University; Oshawa, ON, Canada: School of Health Policy and Management, York University; Toronto, ON, Canada: 2020.</Citation></Reference><Reference><Citation>Mehra M.R., Desai S.S., Kuy S., Henry T.D., Patel A.N. Cardiovascular disease, drug therapy, and mortality in COVID-19. N. Engl. J. Med. 2020;382:e102. doi: 10.1056/NEJMoa2007621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007621</ArticleId><ArticleId IdType="pmc">PMC7206931</ArticleId><ArticleId IdType="pubmed">32356626</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjili R.H., Zarei M., Habibi M., Manjili M.H. COVID-19 as an Acute Inflammatory Disease. J. Immunol. 2020;205:12&#x2013;19. doi: 10.4049/jimmunol.2000413.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000413</ArticleId><ArticleId IdType="pmc">PMC7333792</ArticleId><ArticleId IdType="pubmed">32423917</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.Y., Li L., Zhang Y., Wang X.S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty. 2020;9:45. doi: 10.1186/s40249-020-00662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalsania A.K., Fastiggi M.J., Kahlam A., Shah R., Patel K., Shiau S., Rokicki S., DallaPiazza M. The Relationship between Social Determinants of Health and Racial Disparities in COVID-19 Mortality. J. Racial Ethn. Health Disparities. 2021;9:288&#x2013;295. doi: 10.1007/s40615-020-00952-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-020-00952-y</ArticleId><ArticleId IdType="pmc">PMC7785288</ArticleId><ArticleId IdType="pubmed">33403652</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebenhaar F., Redegeld F.A., Bischoff S.C., Gibbs B.F., Maurer M. Mast Cells as Drivers of Disease and Therapeutic Targets. Trends Immunol. 2018;39:151&#x2013;162. doi: 10.1016/j.it.2017.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2017.10.005</ArticleId><ArticleId IdType="pubmed">29196147</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M.K., Nair A., Gupta M. Mast Cells in Neurodegenerative Disease. Front. Cell. Neurosci. 2019;13:171. doi: 10.3389/fncel.2019.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00171</ArticleId><ArticleId IdType="pmc">PMC6524694</ArticleId><ArticleId IdType="pubmed">31133804</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P., Caraffa A., Ronconi G., Conti C.M., Kritas S.K., Mastrangelo F., Tettamanti L., Theoharides T.C. Impact of mast cells in depression disorder: Inhibitory effect of IL-37 (new frontiers) Immunol. Res. 2018;66:323&#x2013;331. doi: 10.1007/s12026-018-9004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-018-9004-9</ArticleId><ArticleId IdType="pubmed">29907890</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x17b;elechowska P., Agier J., Koz&#x142;owska E., Brzezi&#x144;ska-B&#x142;aszczyk E. Mast cells participate in chronic low-grade inflammation within adipose tissue. Obes. Rev. 2018;19:686&#x2013;697. doi: 10.1111/obr.12670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12670</ArticleId><ArticleId IdType="pubmed">29334696</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez-Enr&#xed;quez E., Hallgren J. Mast Cells and Their Progenitors in Allergic Asthma. Front. Immunol. 2019;10:821. doi: 10.3389/fimmu.2019.00821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00821</ArticleId><ArticleId IdType="pmc">PMC6548814</ArticleId><ArticleId IdType="pubmed">31191511</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinke K.H., Zorzella-Pezavento S.F.G., de Campos Fraga-Silva T.F., Mimura L.A.N., de Oliveira L.R.C., Ishikawa L.W., Fernandes A.A.H., Lara V.S., Sartori A. Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy? Neurotherapeutics. 2020;17:218&#x2013;234. doi: 10.1007/s13311-019-00775-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00775-8</ArticleId><ArticleId IdType="pmc">PMC7007452</ArticleId><ArticleId IdType="pubmed">31463682</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P., Caraffa A., Ronconi G., Kritas S.K., Mastrangelo F., Tettamanti L., Theoharides T.C. Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37. Eur. J. Pharmacol. 2018;818:294&#x2013;299. doi: 10.1016/j.ejphar.2017.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2017.09.044</ArticleId><ArticleId IdType="pubmed">28970014</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermans M.A.W., van Lennep J.E.R., van Daele P.L.A., Bot I. Mast Cells in Cardiovascular Disease: From Bench to Bedside. Int. J. Mol. Sci. 2019;20:3395. doi: 10.3390/ijms20143395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20143395</ArticleId><ArticleId IdType="pmc">PMC6678575</ArticleId><ArticleId IdType="pubmed">31295950</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;gle T. Beyond allergy: The role of mast cells in fibrosis. Swiss Med. Wkly. 2014;144:w13999. doi: 10.4414/smw.2014.13999.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2014.13999</ArticleId><ArticleId IdType="pubmed">25184789</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Chen G. Mast Cell and Autoimmune Diseases. Mediat. Inflamm. 2015;2015:246126. doi: 10.1155/2015/246126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/246126</ArticleId><ArticleId IdType="pmc">PMC4402170</ArticleId><ArticleId IdType="pubmed">25944979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins R.A., Claman H.N., Clark R.A.F., Steigerwald J.C. Increased Dermal Mast Cell Populations in Progressive Systemic Sclerosis: A Link in Chronic Fibrosis? Ann. Intern. Med. 1985;102:182. doi: 10.7326/0003-4819-102-2-182.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-102-2-182</ArticleId><ArticleId IdType="pubmed">3966756</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibold J.R., Giorno R.C., Claman H.N. Dermal mast cell degranulation in systemic sclerosis. Arthritis Care Res. 1990;33:1702&#x2013;1709. doi: 10.1002/art.1780331114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780331114</ArticleId><ArticleId IdType="pubmed">2242067</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakae S., Suto H., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA. 2005;102:6467&#x2013;6472. doi: 10.1073/pnas.0501912102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501912102</ArticleId><ArticleId IdType="pmc">PMC1088381</ArticleId><ArticleId IdType="pubmed">15840716</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalfe D.D., Peavy R.D., Gilfillan A.M. Mechanisms of mast cell signaling in anaphylaxis. J. Allergy Clin. Immunol. 2009;124:639&#x2013;646. doi: 10.1016/j.jaci.2009.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.08.035</ArticleId><ArticleId IdType="pmc">PMC2788154</ArticleId><ArticleId IdType="pubmed">19815110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas J., Delgado M.J.C., Ch&#xe1;vez C., Ch&#xe1;vez-Castillo M., Mej&#xed;a L., Salazar J., Olivar L., Graterol-Rivas M., Wilches-Duran S., Contreras-Vel&#xe1;squez J., et al. Mast cell activation disease associated with autoimmune thyroid disease: Case report and review of literature. Arch. Venez. Farmacol. Ter. 2016;35:92&#x2013;99.</Citation></Reference><Reference><Citation>Tom K., Mehta B.K., Hoffmann A., Aren K., Carns M., Lee J., Martyanov V., Popovich D., Kosarek N., Wood T.A., et al. Mast cell activation in the systemic sclerosis esophagus. J. Scleroderma Relat. Disord. 2020;6:77&#x2013;86. doi: 10.1177/2397198320941322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2397198320941322</ArticleId><ArticleId IdType="pmc">PMC8225255</ArticleId><ArticleId IdType="pubmed">34179507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronca R., Tamma R., Coltrini D., Ruggieri S., Presta M., Ribatti D. Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer. Oncotarget. 2017;8:82583&#x2013;82592. doi: 10.18632/oncotarget.19773.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.19773</ArticleId><ArticleId IdType="pmc">PMC5669912</ArticleId><ArticleId IdType="pubmed">29137286</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltby S., Khazaie K., McNagny K.M. Mast cells in tumor growth: Angiogenesis, tissue remodelling and immune-modulation. Biochim. Biophys. Acta. 2009;1796:19&#x2013;26. doi: 10.1016/j.bbcan.2009.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2009.02.001</ArticleId><ArticleId IdType="pmc">PMC2731828</ArticleId><ArticleId IdType="pubmed">19233249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribatti D., Crivellato E. The controversial role of mast cells in tumor growth. Int. Rev. Cell. Mol. Biol. 2009;275:89&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">19491054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons D.O., Pullen N.A. Beyond IgE: Alternative Mast Cell Activation Across Different Disease States. Int. J. Mol. Sci. 2020;21:1498. doi: 10.3390/ijms21041498.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041498</ArticleId><ArticleId IdType="pmc">PMC7073060</ArticleId><ArticleId IdType="pubmed">32098318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorff S.R., Afrin L.B. Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: A narrative review. J. Obstet. Gynaecol. 2020;40:889&#x2013;901. doi: 10.1080/01443615.2019.1674259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01443615.2019.1674259</ArticleId><ArticleId IdType="pubmed">32148151</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Kaleem Z., Selby D., Afrin L.B. Mast cell deposition and activation may be a new explanation for epiploic appendagitis. BMJ Case Rep. 2018;2018:bcr-2018-224689. doi: 10.1136/bcr-2018-224689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2018-224689</ArticleId><ArticleId IdType="pmc">PMC6157556</ArticleId><ArticleId IdType="pubmed">30249726</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller C.S., Palmer R.F., Dempsey T.T., Ashford N.A., Afrin L.B. Mast cell activation may explain many cases of chemical intolerance. Environ. Sci. Eur. 2021;33:129. doi: 10.1186/s12302-021-00570-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12302-021-00570-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson L.M., Baldwin A.L. Environmental stress causes mast cell degranulation, endothelial and epithelial changes, and edema in the rat intestinal mucosa. Microcirculation. 1999;6:189&#x2013;198. doi: 10.1080/725310748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/725310748</ArticleId><ArticleId IdType="pubmed">10501092</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivera A., Beaven M.A., Metcalfe D.D. Mast cells signal their importance in health and disease. J. Allergy Clin. Immunol. 2018;142:381&#x2013;393. doi: 10.1016/j.jaci.2018.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.01.034</ArticleId><ArticleId IdType="pubmed">29454835</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Tang N., Mao M., Zhou Y., Wu Y., Li J., Zhang W., Peng C., Chen X., Li J. Fine particulate matter (PM2.5) promotes IgE-mediated mast cell activation through ROS/Gadd45b/JNK axis. J. Dermatol. Sci. 2021;102:47&#x2013;57. doi: 10.1016/j.jdermsci.2021.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdermsci.2021.02.004</ArticleId><ArticleId IdType="pubmed">33676788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka H., Tanaka K., Tazuya-Murayama K., Yamashita T., Nishikawa J.-I. Cytotoxic Effects of Water-Soluble Extracts of Coarse and Fine Atmospheric Particulate Matter on Mast Cell Lines. Biol. Pharm. Bull. 2021;44:57&#x2013;62. doi: 10.1248/bpb.b20-00576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b20-00576</ArticleId><ArticleId IdType="pubmed">33390550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopel J., Brower G.L. Impact of fossil fuel emissions and particulate matter on pulmonary health. Bayl. Univ. Med. Cent. Proc. 2019;32:636&#x2013;638. doi: 10.1080/08998280.2019.1641367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08998280.2019.1641367</ArticleId><ArticleId IdType="pmc">PMC6794003</ArticleId><ArticleId IdType="pubmed">31656449</ArticleId></ArticleIdList></Reference><Reference><Citation>Narita S.-I., Goldblum R.M., Watson C.S., Brooks E.G., Estes D.M., Curran E.M., Midoro-Horiuti T. Environmental Estrogens Induce Mast Cell Degranulation and Enhance IgE-Mediated Release of Allergic Mediators. Environ. Health Perspect. 2007;115:48&#x2013;52. doi: 10.1289/ehp.9378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.9378</ArticleId><ArticleId IdType="pmc">PMC1797832</ArticleId><ArticleId IdType="pubmed">17366818</ArticleId></ArticleIdList></Reference><Reference><Citation>Eze C.T., Michelangeli F., Otitoloju A.A., Eze O.O., Ibraheem O., Ogbuene E.B., Ogunwole G.A. Occurrence of chemical pollutants in major e-waste sites in West Africa and usefulness of cytotoxicity and induction of ethoxyresorufin-O-deethylase (EROD) in determining the effects of some detected brominated flame retardants and e-waste soil-derived extracts. Environ. Sci. Pollut. Res. 2021;28:10832&#x2013;10846. doi: 10.1007/s11356-020-11155-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-020-11155-7</ArticleId><ArticleId IdType="pubmed">33099733</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.-J., Sim K.H., Shrestha P., Yang J.-H., Lee Y.J. Perfluorooctane sulfonate and bisphenol A induce a similar level of mast cell activation via a common signaling pathway, Fyn-Lyn-Syk activation. Food Chem. Toxicol. 2021;156:112478. doi: 10.1016/j.fct.2021.112478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2021.112478</ArticleId><ArticleId IdType="pubmed">34363875</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. BioFactors. 2020;46:306&#x2013;308. doi: 10.1002/biof.1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1633</ArticleId><ArticleId IdType="pmc">PMC7267424</ArticleId><ArticleId IdType="pubmed">32339387</ArticleId></ArticleIdList></Reference><Reference><Citation>Azkur A.K., Akdis M., Azkur D., Sokolowska M., Van De Veen W., Br&#xfc;ggen M.-C., O&#x2019;Mahony L., Gao Y., Nadeau K., Akdis C.A. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75:1564&#x2013;1581. doi: 10.1111/all.14364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14364</ArticleId><ArticleId IdType="pmc">PMC7272948</ArticleId><ArticleId IdType="pubmed">32396996</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Geng M., Peng Y., Meng L., Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 2020;10:102&#x2013;108. doi: 10.1016/j.jpha.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7104082</ArticleId><ArticleId IdType="pubmed">32282863</ArticleId></ArticleIdList></Reference><Reference><Citation>Debuc B., Smadja D.M. Is COVID-19 a New Hematologic Disease? Stem Cell Rev. Rep. 2020;17:4&#x2013;8. doi: 10.1007/s12015-020-09987-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-09987-4</ArticleId><ArticleId IdType="pmc">PMC7217340</ArticleId><ArticleId IdType="pubmed">32399806</ArticleId></ArticleIdList></Reference><Reference><Citation>Nile S.H., Nile A., Qiu J., Li L., Jia X., Kai G. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66&#x2013;70. doi: 10.1016/j.cytogfr.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7204669</ArticleId><ArticleId IdType="pubmed">32418715</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson M.P., Jack A.S. Coronavirus disease 2019 (COVID-19) in neurology and neurosurgery: A scoping review of the early literature. Clin. Neurol. Neurosurg. 2020;193:105866. doi: 10.1016/j.clineuro.2020.105866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.105866</ArticleId><ArticleId IdType="pmc">PMC7179494</ArticleId><ArticleId IdType="pubmed">32389893</ArticleId></ArticleIdList></Reference><Reference><Citation>Krystel-Whittemore M., Dileepan K.N., Wood J.G. Mast Cell: A Multi-Functional Master Cell.  [(accessed on 26 May 2022)];Front. Immunol. 2016 6:620. doi: 10.3389/fimmu.2015.00620. Available online:  https://www.frontiersin.org/article/10.3389/fimmu.2015.00620.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00620</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2015.00620</ArticleId><ArticleId IdType="pmc">PMC4701915</ArticleId><ArticleId IdType="pubmed">26779180</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdaca G., Span&#xf2; F., Contatore M., Guastalla A., Puppo F. Potential use of TNF-&#x3b1; inhibitors in systemic sclerosis. Immunotherapy. 2014;6:283&#x2013;289. doi: 10.2217/imt.13.173.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/imt.13.173</ArticleId><ArticleId IdType="pubmed">24762073</ArticleId></ArticleIdList></Reference><Reference><Citation>Atiakshin D., Buchwalow I., Samoilova V., Tiemann M. Tryptase as a polyfunctional component of mast cells. Histochem. Cell Biol. 2018;149:461&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pubmed">29532158</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent P., Akin C., Bonadonna P., Brockow K., Niedoszytko M., Nedoszytko B., Butterfield J.H., Alvarez-Twose I., Sotlar K., Schwaab J., et al. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions. J. Allergy Clinic. Immunol. 2020;146:300&#x2013;306. doi: 10.1016/j.jaci.2020.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.06.009</ArticleId><ArticleId IdType="pmc">PMC7297685</ArticleId><ArticleId IdType="pubmed">32561389</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J., Anderson D.E., Rathore A.P.S., O&#x2019;Neill A., Mantri C.K., Saron W.A.A., Lee C., Cui C.W., Kang A.E.Z., Foo R., et al. Signatures of mast cell activation are associated with severe COVID-19. medRxiv. 2021 doi: 10.1101/2021.05.31.21255594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.31.21255594</ArticleId></ArticleIdList></Reference><Reference><Citation>Pejler G. Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors. J. Innate. Immunity. 2020;12:357&#x2013;372. doi: 10.1159/000506985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000506985</ArticleId><ArticleId IdType="pmc">PMC7506261</ArticleId><ArticleId IdType="pubmed">32498069</ArticleId></ArticleIdList></Reference><Reference><Citation>Leru P.M. Evaluation and Classification of Mast Cell Disorders: A Difficult to Manage Pathology in Clinical Practice. Cureus. 2022;14 doi: 10.7759/cureus.22177.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.22177</ArticleId><ArticleId IdType="pmc">PMC8841127</ArticleId><ArticleId IdType="pubmed">35174041</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi N., Morovati S., Chan L., Napoleoni C., Mehrani Y., Bridle B.W., Karimi K. Mast Cell Tryptase and Implications for SARS-CoV-2 Pathogenesis. BioMed. 2021;1:136&#x2013;149. doi: 10.3390/biomed1020013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomed1020013</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrath E.L., Berger M., Lopes da Rosa R., Beys-da-Silva W.O. Acmella oleracea Is a Medicinal Plant That Decreases Chymase Activity, Oxidative Stress, and Inflammation: Possible Role in the Adjuvant Treatment of COVID-19. J. Med. Food. 2021;24:1243&#x2013;1244. doi: 10.1089/jmf.2021.0055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2021.0055</ArticleId><ArticleId IdType="pubmed">34665022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastolla U., Chambers P., Abia D., Garc&#xed;a-Bermejo M.L., Fresno M. Is Covid-19 severity associated with ACE2 degradation? Cells. 2021;10:1761. doi: 10.3389/fddsv.2021.789710.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fddsv.2021.789710</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki M., Takai S., Jin D., Muramatsu M. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models. Pharmacol. Ther. 2006;112:668&#x2013;676. doi: 10.1016/j.pharmthera.2006.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2006.05.008</ArticleId><ArticleId IdType="pubmed">16837049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezi B., Chan L., Knapp J.P., Karimi N., Alizadeh K., Mehrani Y., Bridle B.W., Karimi K. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells. Cells. 2021;10:1761. doi: 10.3390/cells10071761.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071761</ArticleId><ArticleId IdType="pmc">PMC8308097</ArticleId><ArticleId IdType="pubmed">34359931</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerappan A., O&#x2019;Connor N.J., Brazin J., Reid A.C., Jung A., McGee D., Summers B., Branch-Elliman D., Stiles B., Worgall S., et al. Mast Cells: A Pivotal Role in Pulmonary Fibrosis. DNA Cell Biol. 2013;32:206. doi: 10.1089/dna.2013.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2013.2005</ArticleId><ArticleId IdType="pmc">PMC3624698</ArticleId><ArticleId IdType="pubmed">23570576</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y., Yang D.K., Spinas E., Kritas S.K., Saggini A., Caraffa A., Antinolfi P., Saggini R., Conti P. Role of TNF in mast cell neuroinflammation and pain. J. Biol. Regul. Homeost. Agents. 2015;29:787&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pubmed">26753638</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbhaiya M., Levine J.M., Bykerk V.P., Jannat-Khah D., Mandl L.A. Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Ann. Rheum. Dis. 2021;80:1352&#x2013;1354. doi: 10.1136/annrheumdis-2021-220732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-220732</ArticleId><ArticleId IdType="pubmed">34158370</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Butterfield J.H., Raithel M., Molderings G.J. Often seen, rarely recognized: Mast cell activation disease &#x2013; a guide to diagnosis and therapeutic options. Ann. Med. 2016;48:190&#x2013;201. doi: 10.3109/07853890.2016.1161231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890.2016.1161231</ArticleId><ArticleId IdType="pubmed">27012973</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzarone B., Veneziani I., Moretta L., Maggi E. Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal. Front. Immunol. 2021;12:728513. doi: 10.3389/fimmu.2021.728513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.728513</ArticleId><ArticleId IdType="pmc">PMC8415022</ArticleId><ArticleId IdType="pubmed">34484238</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonadonna P., Brockow K., Niedoszytko M., Elberink H.O., Akin C., Nedoszytko B., Butterfield J.H., Alvarez-Twose I., Sotlar K., Schwaab J., et al. COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM) J. Allergy Clin. Immunol. Pract. 2021;9:2139&#x2013;2144. doi: 10.1016/j.jaip.2021.03.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.03.041</ArticleId><ArticleId IdType="pmc">PMC8019658</ArticleId><ArticleId IdType="pubmed">33831618</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>